1. Home
  2. SMSI vs INTS Comparison

SMSI vs INTS Comparison

Compare SMSI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith Micro Software Inc.

SMSI

Smith Micro Software Inc.

HOLD

Current Price

$2.68

Market Cap

14.0M

Sector

Technology

ML Signal

HOLD

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$4.78

Market Cap

12.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMSI
INTS
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.0M
12.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
SMSI
INTS
Price
$2.68
$4.78
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
132.7K
64.3K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
62.94
N/A
EPS
N/A
N/A
Revenue
$17,363,000.00
N/A
Revenue This Year
$13.97
N/A
Revenue Next Year
$53.35
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.41
$0.19
52 Week High
$6.13
$8.06

Technical Indicators

Market Signals
Indicator
SMSI
INTS
Relative Strength Index (RSI) 52.35 66.87
Support Level $2.51 $4.50
Resistance Level $6.13 $8.06
Average True Range (ATR) 0.14 0.23
MACD -0.10 0.13
Stochastic Oscillator 19.23 83.34

Price Performance

Historical Comparison
SMSI
INTS

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a late-stage clinical biotechnology company passionately committed to applying scientific leadership in the field of localized cancer reduction to anti-cancer immune activation. Its new approach involves the direct injection into tumors of a product created from DfuseRxSM discovery platform. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its product candidate, INT230-6 comprised of three components: cisplatin, a anti-cancer cytotoxic agent, vinblastine sulfate, also a anti-cancer cytotoxic agent, and an amphiphilic molecule which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection.

Share on Social Networks: